- Analysis: U.S. life science R&D spending will grow to $189.3B in 2013
The U.S. life science sector is expected to spend $189.3 billion in research and development in 2013, up from $181.6 billion this year, driven by improved access to data, according to an analysis by Battelle and R&D Magazine. Out of the 275 life science firms that responded to a survey, a majority anticipate their R&D investment to grow over 2012 and 40% said they would participate in more collaborative research next year. MedCityNews.com (12/19)        | Get the tools and flexibility you need to manage your business:
• The ability to set an individual credit limit for each employee card
• Access to a CitiBusiness 24-hour Personal Business Assistant to help with travel, hotel and dining arrangements and more
• Annual and Quarterly Account Summaries online to track business spending by employee, spending category and amount
Learn more. |
  | Health Care & Policy |  |  | | - FDA-approved trial to use telemonitoring, crowdsourcing approaches
A Phase II clinical trial to examine the effectiveness of lisinopril in patients with multiple sclerosis by Transparency Life Sciences was approved by the FDA. The 12-month trial, which is the first to implement both remote monitoring and crowdsourcing techniques, will be performed by the biopharmaceutical startup with telehealth firm AMC Health. MedCityNews.com (12/18) | Company & Financial News | | | | | Industry Deals | | | | | Food & Agriculture | | | | - EFSA supports safety of Monsanto's biotech maize pollen for food use
A European Food Safety Authority panel concluded that Monsanto's MON 810 maize pollen is safe for use "in or as foods." "[T]he genetic modification in maize MON 810 does not constitute an additional health risk if maize MON 810 pollen is to replace maize pollen from non-GM maize in or as food," the panel said. The panel's scientific opinion supports Monsanto's application to bring the maize pollen in the market. FoodNavigator (12/19) | Industrial & Environmental | | | | - House, Senate agree to keep Defense Dept.'s biofuels program
The House of Representatives and the Senate have struck a deal to strip a provision from the defense authorization bill that would limit the military's ability to purchase biofuels. "This new compromise language will allow [the Department of Defense] to move forward with its clean energy agenda unscathed," said Stephanie Dreyer, a spokeswoman for the Truman National Security Project. The Hill/E2 Wire blog (12/18) | News from BIO | | | | - BIOtechNOW
BIOtechNOW is the first in a number of new products from BIO intended to enhance our communications with the biotech community -- not only with our members, but with other stakeholders as well. This e-newsletter, combined with its website, serves as our flagship in that effort. BIOtechNOW will offer original content that emphasizes the business needs of the industry; highlight BIO's advocacy efforts; and provide a portal to all BIO activities and events. Most importantly, it will spotlight for those outside the industry the value of biotechnology. Sign up for the e-newsletter.
| SmartQuote | | | |  | No man for any considerable period can wear one face to himself and another to the multitude, without finally getting bewildered as to which may be the true."
--Nathaniel Hawthorne,
American author  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Wednesday, December 19, 2012
- Tuesday, December 18, 2012
- Monday, December 17, 2012
- Friday, December 14, 2012
- Thursday, December 13, 2012
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2012 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment